Merck
CN
Search Within
文件类型

206-319-3

应用筛选条件
关键词:'206-319-3'
显示 1-30 共 43 条结果 关于 "206-319-3" 范围 技术文档
Antibody SourceBook, Sixth Edition, DIST version
50 µg €319 Anti-Aquaporin 1 (2�3-261) Rabbit pAb FS, IB human, rat 178611 1 Set €206 Anti-Aquaporin 2 (25�-271) Rabbit pAb IB, IH, IP human, mouse, rat 178612 1 Set €206 Anti-Aquaporin 3 (275-292
TB029
Alw44I 3 2060 2560 3806 AlwNI 1 2662 ApaBI 1 823 ApoI 1 4132 AvaI 1 1196 AvaII 8 570 658 907 1210 1252 1531 3277 3499 BamHI 1 4 BanI 7 184 205 319 537 976 1060 3087 BanII 2 246 260 BbsI 3 501 1364
XP725 Antibody Number-Lot Number 071M4826
247 248 269 270 271 272 3.3 201 202 203 204 225 226 227 228 249 250 251 252 273 274 275 276 3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280 3.5 209 210
Data Sheet - 77237
Hematol., 2, 121-128 (1980). Monocytes Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206 (1991). Osipovich, O.A. et al., In vitro. Biull. Eskp. Biol. Med, 113, 638-640 (1992).
Product Information Sheet - E0414
. Lab. Hematol., 2, 121-128 (1980). Monocytes Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206 (1991). Osipovich, O.A. et al., In vitro. Biull. Eskp. Biol. Med, 113, 638-640 (1992). Giddings, J.C
Product Information Sheet - P4937
. Lab. Hematol., 2, 121-128 (1980). Monocytes Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206 (1991). Osipovich, O.A. et al., In vitro. Biull. Eskp. Biol. Med, 113, 638-640 (1992). Giddings, J.C
Percoll - Product Information Sheet
Hematol., 2, 121-128 (1980). Monocytes Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206 (1991). Osipovich, O.A. et al., In vitro. Biull. Eskp. Biol. Med, 113, 638-640 (1992). Giddings
Product Information Sheet - P7828
. Lab. Hematol., 2, 121-128 (1980). Monocytes Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206 (1991). Osipovich, O.A. et al., In vitro. Biull. Eskp. Biol. Med, 113, 638-640 (1992). Giddings, J.C
Product Information Sheet - P1644
. Lab. Hematol., 2, 121-128 (1980). Monocytes Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206 (1991). Osipovich, O.A. et al., In vitro. Biull. Eskp. Biol. Med, 113, 638-640 (1992). Giddings, J.C
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
protein 83 1 163 3 207 4 212 5 133 3 259 4 206 3 319 6 IPI00550640 IGHG4 protein 275 4 111 2 338 3 82 2 337 6 86 2 391 4 193 4 270 4 329
White Paper: The Viscosity Reduction Platform
PEGylated proteins: Fouling and concentration polarization effects, Journal of Membrane Science 319, 206-213, 2008,
BRAND Katalog EN
317 08 - 319 08 146 319 09 147 319 20 146 319 21 147 319 28 146 319 29 147 319 38 146 319 39 147 319 48 146 319 49 147
Calbiochem Biologics 30.2
Karin, M., et al. 2004. Nat. Rev. Drug Dis. 3, 17; Greten, F.R., and Karin, M. 2004. Cancer Lett. 206, 193; Jones, W.K., et al. 2003. Cardiovasc. Toxicol. 3 229; Richmond, A. 2002. Nat. Rev. Immunol
Katalog neoLab
274 2-8420 2 7 394 319 2-8421 2 8 394 365 2-8422 2 9 394 411 2-8423 3 6 573
XP725 Antibody List Lot 129K4831
3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d 208 Cytokeratin peptide 13 C0791
XP725 Antibody List Lot 129K4830
3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d 208 Cytokeratin peptide 13 C0791
XP725 Antibody List Lot 089K4791
3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d 208 Cytokeratin peptide 13 C0791
Cytoskeletal Signaling Antibodies, Reagents and Kits
Conjugate Anti-phospho-MBP, HRP conj. ELISA KA WB 50 µL 16-198 Anti-phospho-MBP, HRP conj. 50 µL 16-206 Protein MBP (myelin basic protein), bovine, purified KA 10 mg 13-104 MBP, Dephosphorylated
List of Antibodies
C5176 M y n/d n/d 204 Cytokeratin CK5 C7785 M y n/d n/d 205 Cytokeratin peptide 7 C6417 M y n/d n/d 206 Cytokeratin 8.12 C7034 M y n/d n/d 207 Cytokeratin 8.13 C6909 M y n/d n/d 208 Cytokeratin peptide 13
Chrombook (WEB-Version)
subtracted -MS, 8.5-9.3 min, background subtractedIbuprofen M=206 Fenoprofen M=206 M-H-CO2 209.0 197.1 241.0 482.9 161.2 205.1 411.0433.2 505.0 M-H 253.0 2M-H 506.9 2M-2H+
XP725 Antibody List
http://www.sigmaaldrich.com/ProductLookup.html?ProdNo=G7670&Brand=SIGMA� 3 9 3 9 3 9 3 9 3 9 3 9 3 9 T 3 3 9 3 9 334 HDAC-7 H6663 56233, 51564 HDAC7A,Hdac7a NP_062518.2,NP_057680.3 M y y n
3D BIOPRINTING: Printing a Brighter Future
, C.; Yoo, J.; Atala, A. Nat. Biotechnol. 2016, 34 (3), 312–319. Figure 3. In-house-developed combinatory bioprinting technology: A) view of the Hybprinter machine, B) FDM module and SLA vat of Hybprinter
3D BIOPRINTING: Printing a Brighter Future
, C.; Yoo, J.; Atala, A. Nat. Biotechnol. 2016, 34 (3), 312–319. Figure 3. In-house-developed combinatory bioprinting technology: A) view of the Hybprinter machine, B) FDM module and SLA vat of Hybprinter
Halal Certificate
23SI5M30 206. 2-Undecen-1-Ol W406801 A99884 HC-23SIM320 207. 3-(METHYLTHIO)-1-HEXANOL W343803 C44272 HC-23SIAT77 208. 3-(METHYLTHIO)-1-HEXANOL NATURAL W343847 D23337 HC-23SIO560 209. 3-(METHYLTHIO
Halal Certificate
22SIU951 206. 2-Undecen-1-Ol W406801 A99884 HC-22SI2S41 207. 3-(METHYLTHIO)-1-HEXANOL W343803 C44272 HC-22SIHP98 208. 3-(METHYLTHIO)-1-HEXANOL NATURAL W343847 D23337 HC-22SIU681 209. 3-(METHYLTHIO
XP725 Worksheet for Lot Number 071M4826
C9987 314 2 3 4 2 Negative Control C9987 315 2 3 4 3 Cdk4 C8218 316 2 3 4 4 Cdk4 C8218 317 2 3 4 5 Cdk6 C8343 318 2 3 4 6 Cdk6 C8343 319 2 3 4 7 Cdk7 cak C7089 320 2
XP725 Antibody List 013M4793
3875 KRT18 NP_954657.1 M y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3 M y n/d n/d 206 Cytokeratin 8.12 C7034 3866, 3860, 3868 KRT15,KRT16,KRT13 NP_002266.2,NP_705694.2,NP_005548.2 M y n
Inhibitor Sourcebook 3rd Edition
.................................. 206 Mitochondrial Function Inhibitors ......................................................................................... 206 Ornithine Decarboxylase Inhibitors
User Guide - 1.73016 - Analytical Procedures and Annexes - English
mg/l Ninhydrin 319 Protein BCA 3) 200 – 1000 µg/l BSA Bicinchoninic acid (BCA) 315 Protein Biuret Low Range 3) 0.5 – 5.0 g/l BSA Biuret reaction 316 Protein Biuret High Range 3) 1 – 10 g/l
Analytical Procedures and Annexes - 1.73026
mg/l Ninhydrin 319 Protein BCA 3) 200 – 1000 µg/l BSA Bicinchoninic acid (BCA) 315 Protein Biuret Low Range 3) 0.5 – 5.0 g/l BSA Biuret reaction 316 Protein Biuret High Range 3) 1 – 10 g/l
1/2